Home
Login
Help
Search this site:
Registered Trials
By recruitment status
By sponsor
By registration date
Advanced search for trials
Registration process
To register a trial
Sponsor registration form
RPCEC trial registration Data Set
To update a registered trial
To disclosure the results of registered trial
Home
|
By sponsor
INSTITUTO FINLAY DE VACUNAS
Trials shown by sponsor
Public title
Date of Registration
State
A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.
2008-07-29
Registered
A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine.
2008-07-29
Registered
A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.
2008-07-29
Registered
Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain.
2008-09-12
Registered
Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.
2008-07-29
Registered
Clinical Trial with the Outer Membrane Vesicles (OMV) Bivalent AW135 Anti meningocóccal Vacccine Candidate
2013-06-19
Registered
Community intrevention trial with VCN7-T in pediatric population, 2017-2021 (NeumoEfect)
13/10/2017
Registered outdated
CV638 ability to protect against homologous Vibrio cholerae 3008 virulent strain
29/12/2016
Registered
Evaluation of the synergistic effect of sequential administration of two immunostimulant products: Immuno-1 and Immuno-2 for the stimulation of the immune response in older adults. Exploratory study
22/05/2020
Registered outdated
Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba.
2008-09-19
Registered
Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique.
2008-09-12
Registered
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 .
06/11/2014
Registered
Phase III study of the Cuban vaccine candidate VCN7-T in patients from 1 to 18 years of age at risk of pneumococcal disease in Havana
04/10/2023
Registered
Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants.
2008-07-29
Registered
Randomized double blind controlled, phase I clinical trial, to assess safety, reactogenicity and immunogenicity of the 638 vaccine candidate, in healthy female and male children and adolescents aged from 5 to 17 years old from Cienfuegos Province, Cuba.
11/10/2013
Registered
Safety and immunogenicity of VCN7-T in infants of 2 and 3 months. Phase I/II.
28/04/2017
Registered outdated
Sinopharm-SOBERANA COVID-Cienfuegos
30/08/2022
Registered
SOBERANA - INTERVENTION
19/03/2021
Registered
SOBERANA 01
13/08/2020
Registered outdated
SOBERANA 01A
17/10/2020
Registered
1
2
next ›
last »
About the RPCEC
Structure and governance
Policy
Publications
Awards
Communications
News
Useful resources
Fundamentals of the registry
References of clinical trials
Cuban regulations
Other registries
International Clinical Trials Registry Platform